Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia

J Nerv Ment Dis. 1996 Feb;184(2):133-5. doi: 10.1097/00005053-199602000-00015.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Agoraphobia / epidemiology
  • Agoraphobia / psychology
  • Agoraphobia / therapy*
  • Analysis of Variance
  • Behavior Therapy*
  • Benzodiazepines / adverse effects
  • Benzodiazepines / therapeutic use*
  • Combined Modality Therapy
  • Comorbidity
  • Depressive Disorder / diagnosis
  • Depressive Disorder / epidemiology
  • Double-Blind Method
  • Fluvoxamine / adverse effects
  • Fluvoxamine / therapeutic use
  • Humans
  • Middle Aged
  • Panic Disorder / epidemiology
  • Panic Disorder / psychology
  • Panic Disorder / therapy*
  • Personality Inventory
  • Placebos
  • Probability
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Placebos
  • Benzodiazepines
  • Fluvoxamine